CLIVARIN 1432UI / 0.25ml injectible solution medication leaflet

B01AB08 • reviparin • Blood and blood forming organs | Antithrombotic agents | Heparin group

Reviparin is an anticoagulant from the low molecular weight heparin class, used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It works by inhibiting coagulation factors, reducing blood clot formation.

The medication is administered subcutaneously, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and undergo regular blood tests to monitor coagulation.

Patients should be aware of potential side effects, such as bleeding, bruising, or injection site reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include bleeding, bruising, and injection site reactions. In rare cases, severe reactions such as heparin-induced thrombocytopenia or major bleeding may occur. Patients should be informed of these risks before use.